Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The receptor for hyaluronate-mediated motility—commonly known as RHAMM/HMMR—is an evolutionarily conserved regulator involved both inside the cell (mitotic spindle function) and at the interface between cells/extracellular matrix where it mediates responses crucial to development, wound healing—and notably—invasion/metastasis across diverse tumor types through its interaction with hyaluronic acid.
Targeting HA/RHAMM interactions to modulate inflammation/fibrosis/tumor progression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor for Hyaluronate-Mediated Motility (RHAMM).